peptide wiki

Mechanism

Pre-mixed blend of Tesamorelin (a stabilized GHRH(1-44) analog) and Ipamorelin (a selective ghrelin-receptor agonist). Tesamorelin is FDA-approved as Egrifta for HIV-associated lipodystrophy; Ipamorelin is not FDA-approved. The blend itself is NOT clinically validated — no controlled trial has tested Tesamorelin co-administered with Ipamorelin. Evidence is inferred from the individual components.

Identification